Royal Bank of Canada »

Keros Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-03-31 $169k 2.5k 67.48
2023-12-31 $355k 8.9k 39.80
2023-09-30 $185k 5.1k 36.04
2023-06-30 $207k 5.1k 40.39
2022-12-31 $148k 3.0k 50.00
2022-09-30 $18k 479 37.50
2021-06-30 $47k 1.2k 40.00
2021-03-31 $79k 1.3k 61.71
2020-12-31 $31k 446 69.36
2020-09-30 $4.0k 101 39.60
2020-06-30 $4.0k 100 40.00